Skip to main content
    P

    Profusa, Inc. Common Stock (PFSA)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.41
    -0.04 (-9.44%)

    Market Cap: $271,330

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Profusa, Inc. Common Stock (PFSA) Financials: Revenue, Profit and Cash Flow

    Updated Aug 19, 2026. Financial statements from company filings, amounts in US dollars.

    Profusa, Inc. Common Stock reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$35.82M, operating cash flow was -$16.25M and free cash flow was -$16.26M. The quarter ended Jun 30, 2026 had revenue of $0 and net income of -$8.76M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $13.22M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2021 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Research and development$2.80M$1.61M$2.04M$4.20M$7.66M
    Operating income-$13.22M-$4.50M-$6.07M-$11.14M-$11.69M
    Net income-$35.82M-$9.23M-$10.28M-$20.22M-$10.31M
    EBITDAN/AN/A-$6.00MN/A-$5.05M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$75.00K$0$0N/A
    Gross profit-$2.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Operating income-$2.54M-$4.01M-$3.57M-$21.71M-$967.08K-$1.42M-$309.80K-$1.10M-$253.13K-$1.31M-$460.16K
    Net income-$8.76M-$3.46M-$8.57M-$22.19M-$8.20M-$2.72M-$7.59M-$2.50M-$397.49K-$2.38M$235.97K
    Last 11 quarters

    Balance Sheet

    As of Dec 2025, total debt of $14.81M exceeded cash and equivalents by $13.04M. Shareholder equity was negative, at -$26.66M, as total liabilities of $30.43M exceeded total assets of $3.77M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Total assets$3.77M$3.07M$1.89M$1.03M$11.36M
    Current assets$3.76M$260.00K$333.00K$160.00K$958.00K
    Cash and equivalents$1.78M$191.00K$142.00K$78.00K$856.00K
    Total liabilities$30.43M$122.28M$111.89M$100.80M$95.02M
    Short-term debt$6.94M$48.21M$40.40M$31.03M$15.76M
    Long-term debt$7.88MN/AN/AN/A$1.19M
    Shareholder equity-$26.66M-$119.20M-$110.00M-$99.77M-$83.66M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.04M$862.00K$3.77M$4.25M$1.96M$3.24M$8.39M$8.78M$8.59M$8.50M$10.88M
    Total liabilities$28.17M$29.06M$30.43M$38.21M$23.14M$125.16M$13.01M$5.82M$5.11M$4.63M$5.09M
    Cash and equivalents$719.00K$375.00K$1.78M$3.01M$662.76K$19.00K$16.20K$533$6.50K$5.31K$4.52K
    Shareholder equity-$27.13M-$28.20M-$26.66M-$33.96M-$21.18M-$121.92M-$4.62M$2.97M$3.48M$3.87M$5.79M
    Last 11 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Operating cash flow-$16.25M-$2.07M-$4.40M-$7.70M-$10.69M
    Capital expenditures$8.00K$0$2.00K$0$0
    Free cash flow-$16.26M-$2.07M-$4.40M-$7.70M-$10.69M
    Investing cash flow-$2.01MN/A-$2.00KN/AN/A
    Financing cash flow$19.84M$2.12M$4.47M$6.92M$8.75M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.63M-$2.58M-$5.13M-$10.62M-$139.17K-$537.00K-$327.52K-$1.15M-$394.88K-$742.00K-$345.21K
    Capital expenditures$73.00K$5.00K$0$4$3$0$4$0$0$0$0
    Free cash flow-$2.71M-$2.58M-$5.13M-$10.62M-$139.18K-$537.00K-$327.52K-$1.15M-$394.88K-$742.00K-$345.21K
    Last 11 quarters

    Frequently Asked Questions About PFSA

    What is Profusa, Inc. Common Stock's annual revenue?

    Profusa, Inc. Common Stock reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Profusa, Inc. Common Stock profitable?

    No. Profusa, Inc. Common Stock reported net income of -$35.82M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does PFSA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$16.25M minus capital expenditures of $8.00K produced free cash flow of -$16.26M.

    How much debt does Profusa, Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $7.88M, short-term debt of $6.94M and cash and equivalents of $1.78M.